These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3529993)

  • 1. Two-year follow-up of exposure and imipramine treatment of agoraphobia.
    Mavissakalian M; Michelson L
    Am J Psychiatry; 1986 Sep; 143(9):1106-12. PubMed ID: 3529993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
    Mavissakalian M; Michelson L
    J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia.
    Mavissakalian M
    J Clin Psychiatry; 1990 May; 51(5):184-8. PubMed ID: 2335493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo.
    Zitrin CM; Klein DF; Woerner MG; Ross DC
    Arch Gen Psychiatry; 1983 Feb; 40(2):125-38. PubMed ID: 6337578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agoraphobics 5 years after imipramine and exposure. Outcome and predictors.
    Lelliott PT; Marks IM; Monteiro WO; Tsakiris F; Noshirvani H
    J Nerv Ment Dis; 1987 Oct; 175(10):599-605. PubMed ID: 3309186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of agoraphobia with group exposure in vivo and imipramine.
    Zitrin CM; Klein DF; Woerner MG
    Arch Gen Psychiatry; 1980 Jan; 37(1):63-72. PubMed ID: 6101535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.
    Klein DF; Ross DC; Cohen P
    Arch Gen Psychiatry; 1987 Apr; 44(4):377-85. PubMed ID: 2882736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework.
    Marks IM; Gray S; Cohen D; Hill R; Mawson D; Ramm E; Stern RS
    Arch Gen Psychiatry; 1983 Feb; 40(2):153-62. PubMed ID: 6130752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of imipramine and behavior therapy on panic disorder with agoraphobia.
    Mavissakalian M
    Psychopharmacol Bull; 1989; 25(1):27-9. PubMed ID: 2672069
    [No Abstract]   [Full Text] [Related]  

  • 10. Imipramine with or without cognitive-behavior therapy in the treatment of an agoraphobic.
    Last CG; Barlow DH; O'Brien GT
    Psychol Rep; 1983 Aug; 53(1):103-14. PubMed ID: 6635054
    [No Abstract]   [Full Text] [Related]  

  • 11. Two-year follow-up of agoraphobics after exposure and imipramine.
    Cohen SD; Monteiro W; Marks IM
    Br J Psychiatry; 1984 Mar; 144():276-81. PubMed ID: 6367875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial depression and response to imipramine in agoraphobia.
    Mavissakalian M
    J Nerv Ment Dis; 1987 Jun; 175(6):358-61. PubMed ID: 3295112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of short-term treatment regimens in phobic patients: a preliminary report.
    Zitrin CM; Klein DF; Lindemann C; Tobak P; Rock M; Kaplan JE; Ganz VH
    Proc Annu Meet Am Psychopathol Assoc; 1976; (64):233-50. PubMed ID: 4791
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine in the treatment of agoraphobia: dose-response relationships.
    Mavissakalian M; Perel J
    Am J Psychiatry; 1985 Sep; 142(9):1032-6. PubMed ID: 3895987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomic changes after treatment of agoraphobia with panic attacks.
    Roth WT; Telch MJ; Taylor CB; Agras WS
    Psychiatry Res; 1988 Apr; 24(1):95-107. PubMed ID: 3393620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipramine, behavior therapy, and phobia.
    Zitrin CM; Klein DF
    Psychopharmacol Bull; 1975 Oct; 11(4):41-2. PubMed ID: 1105642
    [No Abstract]   [Full Text] [Related]  

  • 18. Imaginal flooding and exposure to real phobic situations: treatment outcome with agoraphobic patients.
    Mathews AM; Johnston DW; Lancashire M; Munby M; Shaw PM; Gelder MG
    Br J Psychiatry; 1976 Oct; 129():361-71. PubMed ID: 10036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined pharmacological and behavioral treatment for agoraphobia.
    Telch MJ; Agras WS; Taylor CB; Roth WT; Gallen CC
    Behav Res Ther; 1985; 23(3):325-35. PubMed ID: 2860892
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment: 2.9-year naturalistic follow-up study.
    Nagy LM; Krystal JH; Charney DS; Merikangas KR; Woods SW
    J Clin Psychopharmacol; 1993 Feb; 13(1):16-24. PubMed ID: 8098050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.